Recall MonitorMint Pharmaceuticals Mint-Losartan/HCTZ product recall (2021-10-25)
Health Products
Basic Details
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Summary
Product
A. Mint-Losartan/HCTZ 50mg/12.5mg
Products
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|---|---|---|---|---|
| 2005006807, 2005006808, 2005006809, 2005006810, 2105002149 | B. Mint-Losartan/HCTZ 100mg/12.5mg |
| DIN 02389665 | Tablet | Losartan 100mg Hydrochlorohiazide 12.5mg |
| 1805012687, 1805012688, 1805012689, 1805012792, 1905001010, 1905001011, 2005006947, 2005006949, 2005006950, 2005006951, 2005007297, 2005007298, 2005013776, 2105002150 | C. Mint-Losartan/HCTZ 100mg/25mg |
| DIN 02389673 | Tablet | Losartan 100mg Hydrochlorohiazide 25mg |
| 2005006959, 2005006960, 2005006961, 2005006962, 2005006963, 2005011154, 2005011156 | A. Mint-Losartan/HCTZ 50mg/12.5mg |
| DIN 02389657 | Tablet | Losartan 50mg Hydrochlorohiazide 12.5mg |
Introduction
A. Mint-Losartan/HCTZ 50mg/12.5mg
B. Mint-Losartan/HCTZ 100mg/12.5mg
C. Mint-Losartan/HCTZ 100mg/25mg
Reason
Presence of impurity Losartan Azide ((5-(4'-((5-(azidomethyl)-2-butyl-4-chloro-1H-imidazol-1-yl) methyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole)) above the acceptable concentration limit in affected lots.
Depth of distribution
Retailers, Wholesalers